The Patent Finder

Remedy Pharmaceuticals, Inc.

24 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Oct 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Methods of Intravenous Administration of Glyburide (US 10,391,053) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Apr 1, 2027
    The maintenance fee for Formulations and Methods for Lyophilization and Lyophilates Provided Thereby (US 10,426,729) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
  • 1 fee due Aug 9, 2027
    The maintenance fee for Methods of Intravenous Administration of Glyburide (US 9,254,259) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Methods of treating injuries or conditions related to CNS edema (US 11,951,085) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026
  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,441,556Composition Containing Glibenclamide
In force
 · Medium confidence
In forceMedium confidence
US 10,758,503Composition Containing Glibenclamide
In force
 · Medium confidence
In forceMedium confidence
US 10,426,729Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
In force
 · High confidence
In forceHigh confidence
US 10,869,835Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
In force
 · Medium confidence
In forceMedium confidence
US 10,688,111Liquid formulations of compounds active at sulfonylurea receptors
In force
 · USPTO record
In forceUSPTO record
US 8,277,845Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
In force
 · High confidence
In forceHigh confidence
US 9,254,259Methods of Intravenous Administration of Glyburide
In force
 · High confidence
In forceHigh confidence
US 9,561,176Methods of Intravenous Administration of Glyburide
In force
 · High confidence
In forceHigh confidence
US 10,052,280Methods of Intravenous Administration of Glyburide
In force
 · Low confidence
In forceLow confidence
US 10,391,053Methods of Intravenous Administration of Glyburide
In force
 · Medium confidence
In forceMedium confidence
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
Also on record, not counted in the 24: 2 lapsed for an unpaid fee · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited